insights_auto
Outlook: 57.1% bullish·7.1% bearish
Go to analysischevron_right
ILMN:NASDAQ
Illumina Inc
$272.00
arrow_upward
+0.04%(+0.10) 1D
$273.50
arrow_upward
+0.55% (+1.50)bedtimeAfter hours
Closed: Sep 29, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ILMN...
Open
$273.10
High
$278.99
Low
$267.00
Mkt. cap
41.07B
Avg. vol.
3.32M
Volume
0.00
P/E ratio
50.56
52-wk high
$278.99
52-wk low
$88.00
EPS
$5.38
Beta
1.46
Shares outstanding
151.00M
No. of employees
9K
Open
$273.10
High
$278.99
Low
$267.00
Mkt. cap
41.07B
Avg. vol.
3.32M
Volume
0.00
P/E ratio
50.56
52-wk high
$278.99
52-wk low
$88.00
EPS
$5.38
Beta
1.46
Shares outstanding
151.00M
No. of employees
9K
News stories
From web sources and news partners
The Globe and Mail
·
4 hours ago
Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off?
Yahoo Finance
·
14 hours ago
3 Reasons to Sell ILMN and 1 Stock to Buy Instead
Zacks
·
14 hours ago
REGN or ILMN: Which Is the Better Value Stock Right Now?
Yahoo Finance
·
15 hours ago
REGN or ILMN: Which Is the Better Value Stock Right Now?
Profile
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
About Illumina Inc
CEOJacob Thaysen
Employees8.62K
Founded1998
HeadquartersSan Diego, California, United States
SectorHealth care
Websiteillumina.com